We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Angela Vincent MBBS, MSc, FMedSci, FRS

Angela Vincent MBBS, MSc, FMedSci, FRS

Emeritus Professor of Neuroimmunology, Nuffield Department of Clinical Neurosciences, University of Oxford; Honorary Professor at the Institute of Neurology, University College London, United Kingdom

Angela Vincent is Emeritus Professor of Neuroimmunology at the University of Oxford and is an honorary professor at University College London.  Medically qualified, she was an Honorary Consultant in Immunology and established and directed the Oxford Neuroimmunology Service from 1992-2016.  Research interests include serological studies on patients with neuromuscular junction disorders (myasthenia, MuSK-myasthenia, peripheral nerve hyperexcitability) and acquired disorders of the CNS associated with antibodies to receptors and associated proteins (eg. LGI1 and CASPR2, NMDA and glycine receptors).   She also pioneered experimental studies on the role of maternal antibodies in causing susceptibility to neurodevelopmental disorders.


The University of Oxford hold a patent for CASPR2 and LGI1 antibody assays, licenced to Euroimmun AG. Dr. Vincent receives a proportion of royalties.